Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

1 clinical trials · Condition

Record	Firm	Date
An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia (NCT07324889)	Yihao Wang	2026-01-31

Every clearance here is in the API, with alerts when new ones post.